ADHD

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.

The drug's approval was based on 4 clinical studies evaluating the efficacy and safety of Adhansia XR in 883 people who met DSM-5 criteria for ADHD.

Within the group of Spanish patients with ADHD, a specific variation of the LPHN3 gene increased by 40% the risk of nicotine dependence.

Under the settlement and license agreement, Neos has granted Teva the right to manufacture and market its generic version of Cotempla XR-ODT® under the Teva ANDA beginning on July 1, 2026, or earlier under certain circumstances.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

A recent study found that athletes with attention deficit hyperactivity disorder (ADHD) may need to be even more cautious in concussion prevention.

Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.

New research suggests psychiatric diseases that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

New research suggests psychiatric diseases, including ADHD, that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

Prescription medication use for attention-deficit/hyperactivity disorder (ADHD), asthma, and contraception have all increased in children and teens.

Attention-deficit/hyperactivity disorder is a neurodevelopmental mental disorder characterized by difficulty paying attention, excessive activity, and/or impulsivity that interferes with development and/or functioning.

Many patients with ADHD report peers seeking nonmedical prescription stimulant use.

More research needed to determine if ADHD medication is safe to take before and during pregnancy.

Use of drugs that treat attention-deficit/hyperactivity disorder increased among all age groups and in all US geographic regions.

Study finds that ADHD treatment recommendations are not always followed.

Acetaminophen use for 29 days or more during pregnancy linked to a significant risk of attention-deficit/hyperactivity disorder.

Top articles of the week from The American Journal of Pharmacy Benefits.

Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention.

Between 10% and 20% of students in kindergarten through high school have chronic illness.

The fda has approved mydayis (mixed salts of a single-entity amphetamine product, by Shire) to treat attention deficit hyperactivity disorder (ADHD) in patients 13 years or older.

Guanfacine (Intuniv) for attention-deficit hyperactivity disorder (ADHD) shows marked clinical improvement in global functioning.

Methylphenidate (Cotempla XR-ODT) extended-release orally disintegrating tablets approved to treat children with attention-deficit/hyperactivity disorder.